STERIS’ (TSE:STE – Free Report) – Analysts at Cormark cut their FY2025 earnings estimates for STERIS’ in a research report issued on Monday, January 6th. Cormark analyst B. Watson now anticipates that the company will post earnings of $0.38 per share for the year, down from their prior estimate of $0.86. Cormark currently has a “Moderate Buy” rating on the stock.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- Insider Trades May Not Tell You What You Think
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Want to Profit on the Downtrend? Downtrends, Explained.
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Read Stock Charts for Beginners
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
